COVID-19 Blog
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM
Microbix Biosystems Inc. introduces a novel Quality Assessment Product (QAP™) for Hepatitis C Virus (HCV) POCTs at the ADLM conference. This swab-based, room-temperature stable control aims to enhance accessibility and accuracy of HCV testing, especially in low-resource settings.
Microbix Corporate Presentation – Summer 2024
Microbix Corporate Presentation – Summer 2024 Download The Presentation Here >>
![Microbix Hosts Minister Nina Tangri to Open Capacity Expansions](https://microbix.com/wp-content/uploads/2024/06/Microbix-Hosts-Minister-Nina-Tangri-blog.png)
Microbix Hosts Minister Nina Tangri to Open Capacity Expansions
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites.
![Microbix Advances Test-Ingredient Manufacturing Capabilities](https://microbix.com/wp-content/uploads/2024/06/Microbix-Advances-Test-Ingredient-Manufacturing-Capabilities-blog-1.png)
Microbix Advances Test-Ingredient Manufacturing Capabilities
Microbix is a global leader in the production of native Antigens – preparations of purified and inactivated bacteria and viruses essential for the manufacture of “immunoassays.”
Microbix Corporate Presentation — May 2024
Microbix Biosystems Inc. - Our Company Today. Download The Presentation Here >>
![Microbix Reports Strong Results for Q2 Fiscal 2024](https://microbix.com/wp-content/uploads/2023/08/pixel-2.png)
Microbix Reports Strong Results for Q2 Fiscal 2024
Revenues of $5.6 million and Net Income of $0.4 million MISSISSAUGA, CANADA, May 15, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Schedules Release of Results for Q2 Fiscal 2024
Results Release and Webinar Discussion on Morning of May 15, 2024 MISSISSAUGA, CANADA, May 8, 2024 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Collaborator Introduces New Lab Accreditation Program
Microbix Product Supporting Testing for Drug-Resistant Sexually-Transmitted Infection MISSISSAUGA, CANADA, April 25, 2024 – Microbix...
Microbix Presenting at the 2024 Bloom Burton Conference
MISSISSAUGA, CANADA, April 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,...